Kathryn Kwant net worth
Quick answer
Kathryn Kwant's estimated net worth is $9.0M (range $6.3M – $13.5M) as of 2026. Kathryn Kwant is CEO at Engage Bio. Engage Bio valuation.
Kathryn Kwant is CEO at Engage Bio (YC W22). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Acquired
- Education: Bachelor's degree from University of California, Berkeley
- Region: United States of America
- Industries: Healthcare, Therapeutics
- Team size: 10
- Website: http://engagebio.com
Who is Kathryn Kwant?
Kathryn Kwant is a founder at Engage Bio, a company that participated in Y Combinator's Winter 2022 batch.
Highlights:
- University of California, Berkeley
- Y Combinator W22
- Engage Bio
About Engage Bio
Engage Bio has developed Tethosomes, a new class of non-viral DNA which finally unleashes potent, durable, redosable, and scalable genetic medicine.
In 2026 Engage was acquired by Eli Lilly.
FAQ: Kathryn Kwant net worth and Engage Bio valuation
What is Kathryn Kwant's net worth?
Kathryn Kwant's estimated net worth is $9.0M (range $6.3M – $13.5M) as of 2026. Kathryn Kwant is CEO at Engage Bio. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Engage Bio valuation?
Engage Bio's estimated valuation on Entrepreneurial Check is $100.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Kathryn Kwant's role?
Kathryn Kwant is CEO at Engage Bio, a Y Combinator-backed startup (batch W22).